AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC006486.9 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000470087} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGBL4 | ATP/GTP binding protein-like 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AMZ1 | Archaelysin family metallopeptidase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO3 | Anoctamin 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATL1 | Atlastin GTPase 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATOH7 | Atonal homolog 7 (Drosophila) | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATRNL1 | Attractin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
B3GNT4 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT4 | Beta-1,4-N-acetyl-galactosaminyl transferase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
BDNF | Brain-derived neurotrophic factor | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BEGAIN | Brain-enriched guanylate kinase-associated | Predicted intracellular proteins
| | | | | Tissue enhanced |
BEST3 | Bestrophin 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BEX5 | Brain expressed, X-linked 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BHLHE22 | Basic helix-loop-helix family, member e22 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BRINP3 | Bone morphogenetic protein/retinoic acid inducible neural-specific 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BRSK2 | BR serine/threonine kinase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C15orf59 | Chromosome 15 open reading frame 59 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf45 | Chromosome 16 open reading frame 45 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf96 | Chromosome 17 open reading frame 96 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf26 | Chromosome 19 open reading frame 26 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |